<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13(10)</volume><submitter>Sridharan K</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Metformin and proton pump inhibitors (PPIs) are independently associated with vitamin B12 deficiency. Despite frequent co-prescription, particularly in diabetics with gastroesophageal disorders, evidence regarding the combined risk of these medications on vitamin B12 deficiency remains limited. This study aimed to evaluate the real-world risk of vitamin B12 deficiency associated with metformin, PPIs, and their combinations using the United States Food and Drug Administration Adverse Event Reporting System (USFDA AERS) database.&lt;h4>Methods&lt;/h4>We conducted a disproportionality analysis using USFDA AERS data from 2004 to 2024. We assessed whether metformin, PPIs, or their combinations were reported more often than expected with vitamin B12 deficiency and evaluated associat</pubmed_abstract><journal>Diseases (Basel, Switzerland)</journal><pagination>334</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12562576</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Vitamin B12 Deficiency Associated with Metformin and Proton Pump Inhibitors and Their Combinations: Results from a Disproportionality and Interaction Analysis.</pubmed_title><pmcid>PMC12562576</pmcid><pubmed_authors>Sridharan K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Vitamin B12 Deficiency Associated with Metformin and Proton Pump Inhibitors and Their Combinations: Results from a Disproportionality and Interaction Analysis.</name><description>&lt;h4>Background&lt;/h4>Metformin and proton pump inhibitors (PPIs) are independently associated with vitamin B12 deficiency. Despite frequent co-prescription, particularly in diabetics with gastroesophageal disorders, evidence regarding the combined risk of these medications on vitamin B12 deficiency remains limited. This study aimed to evaluate the real-world risk of vitamin B12 deficiency associated with metformin, PPIs, and their combinations using the United States Food and Drug Administration Adverse Event Reporting System (USFDA AERS) database.&lt;h4>Methods&lt;/h4>We conducted a disproportionality analysis using USFDA AERS data from 2004 to 2024. We assessed whether metformin, PPIs, or their combinations were reported more often than expected with vitamin B12 deficiency and evaluated associat</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Oct</publication><modification>2026-05-15T03:16:03.407Z</modification><creation>2026-05-15T03:07:42.909Z</creation></dates><accession>S-EPMC12562576</accession><cross_references><pubmed>41149068</pubmed><doi>10.3390/diseases13100334</doi></cross_references></HashMap>